Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.

Borgatti A, Koopmeiners JS, Sarver AL, Winter AL, Stuebner K, Todhunter D, Rizzardi AE, Henriksen JC, Schmechel S, Forster CL, Kim JH, Froelich J, Walz J, Henson MS, Breen M, Lindblad-Toh K, Oh F, Pilbeam K, Modiano JF, Vallera DA.

Mol Cancer Ther. 2017 May;16(5):956-965. doi: 10.1158/1535-7163.MCT-16-0637. Epub 2017 Feb 13.

2.

A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.

Fritz SE, Henson MS, Greengard E, Winter AL, Stuebner KM, Yoon U, Wilk VL, Borgatti A, Augustin LB, Modiano JF, Saltzman DA.

Vet Med Sci. 2016 Jun 6;2(3):179-190. doi: 10.1002/vms3.32. eCollection 2016 Aug.

3.

Applicability of 3T body MRI in assessment of nonfocal bone marrow involvement of hematopoietic neoplasia in dogs.

Feeney DA, Sharkey LC, Steward SM, Bahr KL, Henson MS, Ito D, O'Brien TD, Jessen CR, Husbands BD, Borgatti A, Modiano J.

J Vet Intern Med. 2013 Sep-Oct;27(5):1165-71. doi: 10.1111/jvim.12151. Epub 2013 Jul 26.

4.

Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

Feeney DA, Sharkey LC, Steward SM, Bahr KL, Henson MS, Ito D, O'Brien TD, Jessen CR, Husbands BD, Borgatti A, Modiano JF.

Comp Med. 2013 Apr;63(2):174-82.

5.

Molecular profiling reveals prognostically significant subtypes of canine lymphoma.

Frantz AM, Sarver AL, Ito D, Phang TL, Karimpour-Fard A, Scott MC, Valli VE, Lindblad-Toh K, Burgess KE, Husbands BD, Henson MS, Borgatti A, Kisseberth WC, Hunter LE, Breen M, O'Brien TD, Modiano JF.

Vet Pathol. 2013 Jul;50(4):693-703. doi: 10.1177/0300985812465325. Epub 2012 Nov 2.

6.

Evaluation of plasma islet amyloid polypeptide and serum glucose and insulin concentrations in nondiabetic cats classified by body condition score and in cats with naturally occurring diabetes mellitus.

Henson MS, Hegstad-Davies RL, Wang Q, Hardy RM, Armstrong PJ, Jordan K, Johnson KH, O'Brien TD.

Am J Vet Res. 2011 Aug;72(8):1052-8. doi: 10.2460/ajvr.72.8.1052.

PMID:
21801062
7.

A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma.

Ito D, Endicott MM, Jubala CM, Helm KM, Burnett RC, Husbands BD, Borgatti A, Henson MS, Burgess KE, Bell JS, Kisseberth WC, Valli VE, Cutter GR, Avery AC, Hahn KA, O'Brien TD, Modiano JF.

J Vet Intern Med. 2011 Jul-Aug;25(4):890-6. doi: 10.1111/j.1939-1676.2011.0756.x.

8.

Immunotherapy with autologous tumour antigen-coated microbeads (large multivalent immunogen), IL-2 and GM-CSF in dogs with spontaneous B-cell lymphoma.

Henson MS, Curtsinger JM, Larson VS, Klausner JS, Modiano JF, Mescher MF, Miller JS.

Vet Comp Oncol. 2011 Jun;9(2):95-105. doi: 10.1111/j.1476-5829.2010.00234.x. Epub 2010 Aug 16.

PMID:
21569195
9.

An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.

Henson MS, Buman BL, Jordan K, Rahrmann EP, Hardy RM, Johnson KH, O'Brien TD.

Amyloid. 2006 Dec;13(4):250-9.

PMID:
17107885
10.

Feline models of type 2 diabetes mellitus.

Henson MS, O'Brien TD.

ILAR J. 2006;47(3):234-42. Review.

PMID:
16804198
11.

Gastrin-secreting pancreatic endocrine tumor in a dog (putative Zollinger-Ellison syndrome).

Hayden DW, Henson MS.

J Vet Diagn Invest. 1997 Jan;9(1):100-3. No abstract available.

PMID:
9087938

Supplemental Content

Loading ...
Support Center